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Reports on phase separation and amyloid formation for multiple proteins and
aggregation-prone peptides are recurrently used to explore the molecular mechanisms
associated with several human diseases. The information conveyed by these reports can
be used directly in translational investigation, e.g., for the design of better drug screening
strategies, or be compiled in databases for benchmarking novel aggregation-predicting
algorithms. Given that minute protocol variations determine different outcomes of
protein aggregation assays, there is a strong urge for standardized descriptions of
the different types of aggregates and the detailed methods used in their production.
In an attempt to address this need, we assembled the Minimum Information Required
for Reproducible Aggregation Experiments (MIRRAGGE) guidelines, considering first-
principles and the established literature on protein self-assembly and aggregation.
This consensus information aims to cover the major and subtle determinants of
experimental reproducibility while avoiding excessive technical details that are of limited
practical interest for non-specialized users. The MIRRAGGE table (template available in
Supplementary Information) is useful as a guide for the design of new studies and as
a checklist during submission of experimental reports for publication. Full disclosure of
relevant information also enables other researchers to reproduce results correctly and
facilitates systematic data deposition into curated databases.
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INTRODUCTION
Aggregation of misfolded proteins and peptides is associated
with common and rare neurodegenerative disorders and
with amyloidoses (Aguzzi and O’Connor, 2010; Chiti and
Dobson, 2017; Benson et al., 2018). Classical neuropathological
hallmarks such as neurofibrillary tangles in Alzheimer’s disease
(AD), Lewy bodies in Parkinson’s disease (PD), or inclusion
bodies in Huntington’s disease, have as main constituent
characteristic polypeptides aggregated in the form of insoluble
highly-ordered structures named amyloid fibrils (Westermark
et al., 2007; Gremer et al., 2017). The definition of amyloid
encompasses morphological (Figure 1A), structural (Figure 1B)
and histological (Figure 1C) aspects. Amyloid polymorphs
are associated with different clinical sub-types of the same
disease (Guo et al., 2013; Qiang et al., 2017; Goedert et al.,
2018), and they exhibit structural differences that can be
characterized at atomic resolution using solid-state nuclear
magnetic resonance with magic angle spinning (ss-NMR) and
cryo-electron microscopy (cryo-EM) techniques (Fitzpatrick
et al., 2013; Qiang et al., 2017; Rasmussen et al., 2017;
Iadanza et al., 2018b). When the amyloid fold is exploited by
nature for functional purposes, the structural variability is less
evident than in disease-related aggregates, thus suggesting that
functional amyloids are the result of naturally evolved amino
acid sequences (Otzen and Riek, 2019). The analogy of a low-
energy “black hole” has been used to illustrate the propensity
of proteins to form amyloid fibrils after incomplete native
folding or if subjected to appropriate denaturing conditions;
under mildly denaturing conditions, native interactions and
intrachain interactions are in competition, so that the occurrence
of transiently stable, non-native conformations may trigger
amyloid fibril formation (Zheng et al., 2013). However, there
are other energetically stable structures into which proteins self-
assemble irrespectively of, prior to, or concomitantly with the
formation of amyloid fibrils (Figure 1D). Of these, the soluble
aggregates of amyloidogenic proteins attract a particular interest
justified by the cytotoxic properties attributed to amyloid-β (Aβ)
oligomers in AD (Ahmed et al., 2010; Yang et al., 2017) and
α-synuclein oligomers in PD (Lorenzen et al., 2014; Ingelsson,
2016). Liquid-liquid phase separation is now recognized as
having a central role in cell physiology and disease (Shin and
Brangwynne, 2017). For example, membraneless compartments
of concentrated proteins/nucleic acids are implicated in diverse
processes, including RNA metabolism, ribosome assembly, DNA
repair and intracellular signaling (Banani et al., 2017). When
the capacity of protein quality control by the proteasome is
exceeded, misfolded proteins are sequestered into intracellular
compartments such as the aggresome, a perinuclear deposit
destined to autophagy (Johnston et al., 1998), or the CytoQ
and INQ, which are deposition sites of misfolded proteins
in the cytosol and the nucleus, respectively (Miller et al.,
2015). On the other hand, a neuropathological hallmark of
sporadic and inherited forms of amyotrophic lateral sclerosis
and frontotemporal dementia is the deposition of poorly soluble
assemblies of mutated RNA-binding proteins in the nucleus
and cytoplasm of neurons (Patel et al., 2015). The pathogenic
mutants are characterized by a diminished ability to reiteratively
shift between dispersed and condensed phases consisting of
dense liquids and gels (Murakami et al., 2015). The physical
properties of the different polypeptide assemblies (summarized
in Figure 1D) are determined by the degrees of molecular and
supramolecular order. Although denser liquid phases relax more
slowly in response to shear deformation, they still lack the
long-range translational order characteristic of solids (Falahati
and Haji-Akbari, 2019). The maximal organization provided by
crystal lattices allows the structure of folded proteins to be solved
using X-ray crystallography. Naturally occurring microcrystals
are also used by living cells for protein storage, protection and
stabilization (Schönherr et al., 2018), whereas in crystallopathies
such as eosinophilic inflammation, protein crystals have been
reported as promising drug targets (Persson et al., 2019).
THERMODYNAMIC AND KINETIC
OBSTACLES TO REPRODUCIBILITY
According to the phase rule of thermodynamics, the maximum
number of stable phases that can coexist within a mixture
is limited to k+ 2, with k being the number of non-reactive
components present in the mixture (Falahati and Haji-Akbari,
2019). The reduced number of accessible microstates due to
demixing implies an entropic penalty of −T1S > 0 reflecting
the disorder-to-order transition (Shin and Brangwynne, 2017;
Falahati and Haji-Akbari, 2019). This entropic cost, which is
higher at higher temperature (T), can be compensated by
the enthalpic contribution (1H < 0) provided that the new
intermolecular interactions are sufficiently strong to decrease
the Gibbs free energy 1G = 1H-T1S. Whether a given protein
undergoes a phase separation or not is, therefore, predictable
according to the information of temperature and composition
given in phase diagrams. In practice, however, differences in the
protein source and sample manipulation generate aggregation
states that are not readily duplicated among distinct laboratories,
a problem that was highlighted in the editorial entitled “State
of Aggregation” of Nature Neuroscience in April, 2011. The
difficulties in reproducing protein self-assembly experiments are
correlated with the occurrence of metastable states of protein
folding (Sohl et al., 1998) and phase separation (Gazit, 2002;
Baldwin et al., 2011) consisting of local free energy minima whose
evolution toward the global minimum takes place over too long
timescales to be biologically realistic. Partially unfolded states that
are more stable than the native fold (Giri Rao and Gosavi, 2018)
and the kinetic trapping of condensates into oligomeric (Miti
et al., 2015) and gel-like states (Alberti, 2017) accentuate the need
for a clear description of the initial state of the protein, its source
and how it was manipulated.
The interplay between protein folding, oligomerization
and metastable phase separation adds uncertainty to the
dynamic distribution of the different species during test-tube
experiments. How cells spatiotemporally regulate these processes
is additionally determined by the occurrence of post-translational
modifications (Boeynaems et al., 2018; González et al., 2019),
chaperone recruitment (Mateju et al., 2017) and macromolecular
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FIGURE 1 | Amyloid and non-amyloid aggregates. (A) Amyloids have the characteristic fibrillar appearance illustrated in this transmission electron microscopy (TEM)
image of negatively stained fibrils from a peptide derived from the SH3 domain of PI3-kinase (SH3-PI3K) (Ventura et al., 2004). The bar corresponds to 200 nm.
(B) The ordered β-sheet structure of amyloid fibrils produces the cross-β X-ray diffraction pattern here exemplified for fibrils of a peptide derived from Mot3 yeast
prion (Sant’Anna et al., 2016; Fernandez et al., 2017). The blue and red arrows indicate typical reflections at 4.7 and 10.2 Å, respectively. (C) Thioflavin-S (Th-S) is an
histological dye that shows fluorescence in presence of amyloid fibrils (example of SH3-PI3K fibrils stained with Th-S) (Ventura et al., 2004). The bar corresponds to
20 µm. (D) Folded and misfolded monomers are in dynamic equilibrium with soluble oligomers and may coexist in solution with different condensates, such as
dense liquids and gels, amyloid fibrils and their protofibrillar precursors, crystals and amorphous solids. For simplicity, the more complex cases of fibril polymorphism,
multiprotein assemblies or nucleic acid-protein assemblies are not shown, and amyloid fibrils are represented as composed of four protofilament units. (B) Adapted
from (Sant’Anna et al., 2016). All copyright permissions have been secured by the authors.
crowding (Aguzzi and Altmeyer, 2016; Rivas and Minton, 2016).
For the molecular-level understanding of protein aggregation,
kinetic results obtained under tightly controlled conditions and
in the presence of specific dyes, such as Thioflavin-T (Th-
T), Thioflavin-S (Th-S) and Congo red (CR), are analyzed
using different nucleation-and-growth models (Crespo et al.,
2012; Meisl et al., 2016; Chatani and Yamamoto, 2018).
A combination of complementary techniques including (but
not limited to) chromatography, light scattering, and advanced
microscopy is required to validate complex mechanisms that
may comprise the formation of intermediate phases (Ianiro
et al., 2019), precursor oligomers (Pieri et al., 2016), reversible
oligomerization (Silva et al., 2017), irreversible oligomerization
(Silva et al., 2018), and conformational transitions (Ruff et al.,
2019), to cite but a few examples. As a stochastic process, primary
nucleation is itself a source of variability in which stable clusters
are formed occasionally as the result of random molecular
collisions (Vekilov, 2010; Sleutel and Van Driessche, 2018).
When nucleation is a rare event, the emergence of measurable
amounts of protein aggregates is preceded by a lag phase
whose variable duration reflects the probability distribution of
a successful event (Crespo et al., 2012; Michaels et al., 2016).
During amyloid fibril formation, prior addition of > 1% of
preformed fibrils (or seeds) is often sufficient to eliminate the
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lag phase and the intrinsic uncertainty associated to primary
nucleation (Sárkány et al., 2019). Conversely, protein samples
containing residual, yet variable, amounts of preformed seeds
may not be suitable for “unseeded” assays due to irreproducible
lag times (Crespo et al., 2012, 2016). In these cases, a final step
of sample polishing immediately before the aggregation assay is
recommended to eliminate vestigial assemblies formed during
storage or upon thawing (Mahler et al., 2009; Silva et al., 2017;
Weinbuch et al., 2018).
AN ONTOLOGICAL APPROACH TO
PROTEIN AGGREGATION
As new published data on protein aggregation and phase
separation proliferate, they increase the risk that different
semantics are adopted to characterize the same entities, or
else, that different entities end up having the same designation.
Motivated by a similar concern, the International Society of
Amyloidosis has created a nomenclature committee whose
periodical reports try to keep pace with the ever-increasing
knowledge of amyloid disorders in humans and animals
(Westermark et al., 2007; Benson et al., 2018). Recent efforts
toward a controlled vocabulary were also taken in the context
of phase separation in living cells (Alberti, 2017; Shin and
Brangwynne, 2017; Boeynaems et al., 2018), or while establishing
guidelines to the use of Th-T in the presence of non-amyloid
species (Gade Malmos et al., 2017). We now propose an
ontological roadmap (Figure 2) and a systematized terminology
(Table 1), considering the established nomenclature and the
fundamental concepts of physical-chemical equilibrium. We
depart from the definition of phase as a region in space with
uniform density and composition at a given pressure and
temperature (Prausnitz et al., 1998). Phase separation, therefore,
refers to a change in density and/or composition that culminates
in the formation of a new phase. The transition of a molecule i
from phase A to the new phase B is driven by the difference in
chemical potential 1µ = µBi − µ
A
i that results from the different




i + RTln (xiγi) (1)
with µ0i being the standard chemical potential and R the universal
gas constant. The depletion of phase A (and the concomitant
enrichment of phase B) in component i proceeds until the
equilibrium condition µAi = µ
B








The formation of a new phase can occur instantaneously by
spinodal decomposition, or via the energy-activated process
of nucleation. In the latter case, thermal and compositional
fluctuations result in the generation of embryos of phase B
with non-zero surface free energy in the phase boundary. The
thermodynamically unstable embryos tend to disintegrate back to
phase A, unless they are larger than the critical size of the primary
nucleus (Vekilov, 2010; Falahati and Haji-Akbari, 2019). Once
this free energy barrier is overcome, phase transition will proceed
at a faster rate if catalyzed by the secondary steps of growth (or
elongation) and templated nucleation (or secondary nucleation)
(Padrick and Miranker, 2002; Crespo et al., 2012; Meisl et al.,
2016; Chatani and Yamamoto, 2018). Alternatively, the initially
homogeneous phase A can be further destabilized by increasing
xi and/or by decreasing T to a point of spinodal decomposition
where phase separation occurs by spontaneous amplification of
infinitesimal phase fluctuations (Falahati and Haji-Akbari, 2019).
The absence of a visible lag phase in aggregation progress curves
does not necessarily mean that the critical nucleus has reached the
minimum size of 1 molecule required for spinodal decomposition
(Vekilov, 2010). Instead, it may happen that the presence of a
nucleation barrier is concealed by (comparatively) fast elongation
and secondary nucleation steps, thus originating the hyperbolic
curves typical of downhill polymerization (Hurshman et al., 2004;
Crespo et al., 2012).
As discussed above, the occurrence of kinetically trapped
species is one of the obstacles for reproducible reporting of
aggregation experiments. While corresponding to an unstable,
high-energy state, the short-lived nucleation embryos are not
included in the catalog of such intermediates. Primary nuclei,
on the contrary, may have a fixed, well-ordered structure at
the moment of their formation, or pass through local spatial
ordering and structural annealing until a free energy minimum
is eventually reached (Murray et al., 2017; Boeynaems et al.,
2018). The sizes of primary and secondary nuclei can be estimated
from the concentration dependences of kinetic parameters such
as the duration of the lag phase and the limit aggregation
rates (Cohen et al., 2013; Dovidchenko et al., 2014; Silva et al.,
2018), but also through direct measurements using dynamic
light scattering (Walters and Murphy, 2011; Silva et al., 2017)
and small-angle X-ray scattering techniques (Vestergaard et al.,
2007). In the hierarchy of amyloid fibril assembly, protofilaments
are the primordial insoluble species and the fibrillar subunit of
the β-sheet stacking (Teplow, 1998; Rochet and Lansbury, 2000;
Khurana et al., 2003; Makin and Serpell, 2005). Protofilaments
intertwine to form small and flexible protofibrils, which are
classified as worm-like, rod-like or fuzzy, according to the
morphological features displayed in, e.g., EM micrographs (Gosal
et al., 2005; Gade Malmos et al., 2017). The elongation and
intertwining of protofibrils give rise to typically straight and
SDS-resistant mature fibrils with length often exceeding 1 µm
and diameter around 10–20 nm (Rochet and Lansbury, 2000;
Eisenberg and Sawaya, 2017; Gade Malmos et al., 2017). Instead
of mature fibrils, the end product of amyloid assembly may
consist of protofibrils, as in the cases of the L55P mutant of
transthyretin at physiological (instead of acidic) pH (Lashuel
et al., 1999), and of ataxin-3 containing a non-expanded (fewer
than ca. 30 glutamine residues) polyglutamine tract (Carvalho
et al., 2018). Equally, dense liquid droplets nucleated after local
enrichment of aggregation-prone proteins can either mediate
new disorder-to-order transitions during crystallization and
amyloid fibril formation (Vorontsova et al., 2015; Aguzzi and
Altmeyer, 2016), or develop into gel-like states with reduced
fluidity and protein movement (Aguzzi and Altmeyer, 2016;
Banani et al., 2017; Boeynaems et al., 2018). Pathway 1 in
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FIGURE 2 | Ontological map of protein aggregation. Phase equilibria (solid outlines) are established between the liquid phase (green circle), the dense liquid phase
(orange circle) and the solid phase (blue circles). The different species (represented as in Figure 1D) may undergo structural transitions (dashed lines) that originate
distinct species within the same stable phase (different shades of color). Visual examples of aggregation pathways are provided, comprising many (arrow 1), some
(arrow 2) and no (arrow 3) intermediate states. Off-pathway aggregation occurring in parallel with amyloid fibrillation is represented by a bifurcation (arrow 2′). The
outcome of phase separation (black dots) is contingent on concentration, temperature, pH, ionic strength, amino acid sequence, etc., but also on the initial state of
the protein, as it determines the point in the green region from where the experiments depart (white dots).
Figure 2 illustrates the formation of mature fibrils preceded
by the occurrence of several intermediate states, including
liquid droplets, gels, and protofibrils. Pathways 2 and 2′ show
the possible coexistence of kinetically arrested states that, in
this illustrative example, correspond to protofibrils and liquid
droplets, respectively. Pathway 3 corresponds to the direct
formation of protein crystals from globular protein.
Protein unfolding and oligomerization (represented in
Figure 2 by green dashed lines) involve the interconversion
between native, partially unfolded, denatured and oligomeric
states of the protein. The equilibrium composition of these
structurally distinct entities results, as in phase separation,
from the balance of chemical potentials; however, each state
of the protein is now characterized by different values of the
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TABLE 1 | Glossary of terms used in protein aggregation phenomena.
Amyloid fibril Insoluble, protease resistant aggregate with characteristic (i) fibrillar electron microscopic appearance, (ii) X-ray fiber diffraction pattern and (iii)
histological staining reactions, including Th-T fluorescence and green birefringence in the presence of Congo red.
Amyloidosis Any disease associated with the formation of amyloid deposits, i.e., deposits that have amyloid fibrils as main constituent.
Condensate The denser phase formed upon phase separation.
Embryo A metastable cluster formed as the result of random molecular collisions; embryos will tend to disintegrate if smaller than the critical nucleus
size.
Liquid demixing Separation of a solution into two coexisting liquid phases (compare with phase separation); also known as “liquid-liquid demixing.”
Mature amyloid fibril A long, fully stable amyloid fibril consisting of intertwined protofilament units producing a wound structure that is resistant to 2% (w/v) sodium
dodecyl sulfate (SDS) treatment.
Nucleation The stochastic process by which nuclei are formed; primary nucleation occurs in the homogeneous bulk solution; secondary nucleation occurs
on the surface of an already existing aggregate; heterogeneous nucleation occurs on the surface of a foreign substance.
Nucleus A cluster formed as the result of random molecular collisions and with the ability to elongate into a fibril (compare with embryo).
Off-pathway oligomer Stable oligomer that coexists with amyloid fibrils but is not an amyloid percursor; off-pathway oligomerization and amyloid fibrillation are
competitive processes.
Oligomer Multimeric species lacking the morphology and properties of amyloid fibrils.
On-pathway oligomer A precursor of amyloid fibrils; the addition of pre-formed on-pathway oligomers accelerates the formation of amyloid fibrils without affecting the
total amyloid conversion.
Phase separation The formation of a new region with uniform density and composition; it can occur instantaneously by spinodal decomposition, or via the
energy-activated process of nucleation.
Protofibril Beaded chain with ∼5 nm diameter and <150 nm length that matures into amyloid fibrils.
Protofilament Subunit of amyloid fibrils; smaller protofilaments with ∼1 nm diameter entwine to form larger protofilament units with 2.5–3.5 nm diameter.
Seed Preformed amyloid particle able to accelerate the assembly of amyloid fibrils.
standard chemical potential µ0i (Eq. 1) (Tanford, 1970). Although
occurring within the same liquid phase, structural transitions
might trigger subsequent phase separations as in the general
case of protein misfolding diseases in which pathologic protein
aggregation arises from the failure of a specific protein or peptide
to adopt its native conformation (Chiti and Dobson, 2006). Also,
insulin amyloid fibril formation is preceded by the aggregation
of a precursor helical oligomer that later becomes the repeating
unit of mature fibrils (Vestergaard et al., 2007), whereas several
of the key proteins present in membraneless organelles have
oligomerization domains that drive liquid demixing through
multiplicative sticky interactions (Boeynaems et al., 2018). In a
different example, amyloid fibrillation of non-expanded ataxin-3
decreases the concentration of soluble monomers, thus causing
the dissociation of off-pathway oligomers to monomeric species
(Silva et al., 2017). Because the different states of protein
aggregation are in dynamic equilibrium, a possible rescue
mechanism includes the sequestration of harmful species into
less toxic aggregates or in phase separated compartments of the
cell (Gosal et al., 2005; Haass and Selkoe, 2007; Boeynaems et al.,
2018). Illustrating this protection mechanism, amyloid plaques
isolated from AD cortex do not elicit toxic effects in rodent
hippocampus unless they are solubilized to release toxic Aβ
dimers (Shankar et al., 2008).
Systematizing protein folding intermediates and oligomeric
species into organized categories is a challenging task due to the
heterogeneity and elusive nature of both populations. Moreover,
many proteins naturally occur as an ensemble of more than
one polypeptide chain folded into a characteristic oligomeric
conformation (Doyle et al., 2013), while others, known as
intrinsically disordered proteins, can sample a continuum of
conformations (Jarosz and Khurana, 2017; Darling et al., 2018).
Folding intermediates have been detected for a limited number
of proteins by measuring the exchange rates of hydrogen atoms
between the main-chain amides and water (Englander et al.,
2016), or by combining 1H liquid-state NMR and multivariate
analysis (Malmendal et al., 2010). Figure 2 necessarily simplifies
the folding landscape that is associated with pathogenic protein
aggregation as different protein-protein interactions are required
to maintain proteostasis in living cells. For example, the correct
folding of prion protein (PrP) is assured by chaperones of the
endoplasmic reticulum such as calnexin (Wang et al., 2010)
and the proline cis/trans isomerase cyclophilin B (Ben-Gedalya
et al., 2015). Conformational variations between the normal
(PrPC) and the infectious (PrPSC) isoforms are responsible for
the recruitment of PrPC by PrPSC during amyloid polymerization
(Prusiner, 2001). The self-templating properties of PrPSC are the
basis for ultrasensitive tests for prion infections in biological
fluids and tissues (Saborio et al., 2001; Orru et al., 2012).
Likewise, the amplification of seeding-competent aggregates
of Aβ peptide (Salvadores et al., 2014), α-synuclein (Fairfoul
et al., 2016) and tau (Saijo et al., 2017) is a promising
technological principle for the diagnosis of AD, PD, and
tauopathies, respectively (Soto and Pritzkow, 2018). Amyloid
seeding capacity can be used to evaluate whether a given
intermediate is on-pathway or off-pathway to form amyloid
fibrils. The maximal seeding potency is achieved upon the
addition of pre-formed, sonicated fibrils. Conversely, off-pathway
oligomers (Farmer et al., 2017; Hasecke et al., 2018), fibril
polymorphs (Kodali and Wetzel, 2007; Falcon et al., 2015; Cao
et al., 2019), and seeds pre-treated with aggregation inhibitors
(Arimon et al., 2008; Oskarsson et al., 2018; Saelices et al., 2018)
are expected to have lower seeding potencies. Amyloid fibrils
produced from distinct proteins can be tested for conformational
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complementarity in cross-seeding experiments, also known as
heterologous or heterogeneous seeding (Harper and Peterand





Significant experimental evidence must be gathered by
complementary biophysical methods to determine if a protein
or peptide does aggregate and if it is specifically able to form
amyloid assemblies. Several computational approaches have been
developed to predict aggregation-prone regions in (poly)peptide
sequences (Belli et al., 2011; Pallarès and Ventura, 2019),
but often experimental validation of aggregation propensity
represents a considerable bottleneck (Grishin et al., 2020).
Protein self-assembly is a complex process that might result in
the formation of amorphous aggregates, different oligomers or
amyloid fibrils, heterogeneous species that often coexist during
the aggregation process. In this section, the methodological
approaches required to identify general protein aggregation
(see section “Monitoring the Presence of Protein Aggregates”)
and to distinguish amyloid fibril formation specifically (see
sections “Methods to Monitor the Conformational Properties
of Amyloid Aggregates,” “Morphology of Amyloid Fibrils,”
and “Fluorescence Techniques and Tinctorial Properties of
Amyloids”) are summarized. In particular, we focus on the study
of amyloid fibril formation, which can be addressed from the
structural (see section “Morphology of Amyloid Fibrils”) and
the kinetic point of view (see section “Fluorescence Techniques
and Tinctorial Properties of Amyloids”). A minimum set of
experiments is suggested to satisfy the criteria that generally
define amyloid aggregates according to their conformational,
morphological and tinctorial properties.
Monitoring the Presence of Protein
Aggregates
The formation of protein aggregates can be detected by a
collection of orthogonal methods that report on different
properties of these macromolecular assemblies.
Light Scattering and Turbidimetry
The aggregated states of proteins or peptides scatter the light
passing through the aggregate solution proportionally to the
size of aggregated particles. Therefore, the course of aggregation
can be monitored by the measurement of an attenuation of
incident light beam (turbidimetry) or by integration of an
angle-specific scattering [static light scattering, SLS (Zhao et al.,
2016)]. Turbidimetry is often taken as a linear descriptor of the
kinetics of aggregation reactions; however, caution should be
taken when comparing different proteins or conditions, since
light is scattered as a function of both aggregate size and shape.
SLS is able to determine the relative size of an aggregate by
measuring the time-averaged intensity of scattered light, usually
employing the same wavelength for excitation and detection at an
angle of 90◦. It reports on the molar mass (weight-average) and
concentration of the aggregate.
Dynamic Light Scattering
Dynamic light scattering (DLS), also known as photon
correlation spectroscopy or quasi-elastic light scattering, is
a spectroscopy technique that measures the fluctuation of
intensity of scattered light with time and is routinely applied
to detect protein aggregates, as well as other nanoparticles
(Zaccai et al., 2017).
Dynamic light scattering allows to derive two basic
characteristics from a protein population. First, the mean
hydrodynamic size, assuming a spherical geometry of the
particle, and second, the polydispersity index of the solution.
DLS is highly sensitive to the presence of aggregates because
light scattering intensity scales with the second power of the
mass of the light scattering particle. Therefore, low amounts
of protein aggregates can be detected when the hydrodynamic
radii are large enough. When the sample contains both
monomeric and aggregated species, the monomer can only
be adequately detected when the polydispersity index is low
and the protein concentration is high. In this case, the particle
size distribution plot shows multiple peaks indicative of a
multimodal distribution.
Size Exclusion Chromatography
Size-exclusion chromatography (SEC) offers the possibility to
identify, collect and determine the relative molecular weight of
the different assemblies in an aggregated sample (Striegel et al.,
2009; Burgess, 2018). Extra care must be exerted when dealing
with labile oligomers. These can be potentially disrupted during
the fractionation process, shifting the equilibrium between
species as a function of the protein concentration. Moreover,
large insoluble aggregates should be filtered out before analysis
to prevent column clogging.
Size-exclusion chromatography becomes a versatile technique
when coupled to multiangle light scattering (MALS) and
differential refractive index (dRI) detectors, which allow to
determine protein concentration, molecular weight (MW), size
and conformation (Folta-Stogniew, 2006). The SEC-MALS
instrument is calibrated independently of the column and
does not depend on commercial reference standards, becoming
the default method for the estimation of native MW on
heterogeneous samples (Sahin and Roberts, 2012).
Intrinsic Fluorescence Spectroscopy
The sensitivity of the intrinsic fluorescence signal of tyrosine
and tryptophan residues to their local environment has
been extensively used to study protein conformation by
fluorescence spectroscopy. A steady-state fluorescence spectrum
is obtained by recording the emission fluorescence intensity of
a sample excited at a fixed wavelength. In proteins, tryptophan
fluorescence is owed to the side-chain indole group, displaying
an absorption maximum at 280 nm and a fluorescence peak
that is solvatochromic, ranging from 300 to 350 nm. Depending
on the polarity of the local environment, the fluorescence
emission maximum ranges from ∼308 nm for a tryptophan
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fully embedded in a hydrophobic pocket to ∼348–352 nm for
a tryptophan fully exposed to solvent (Ghisaidoobe and Chung,
2014). Thus, the fluorescence of tryptophan in monomeric and
aggregated states of proteins is significantly different (Bobone
and van de Weert, 2014). The fluorescence of tyrosine is due
to its side-chain phenolic ring, with excitation and emission
maxima at 260 nm and 305 nm, respectively. When compared
to tryptophan, the fluorescence signal of tyrosine is less sensitive
to environmental changes, as a consequence of the lack of
dipole reorientation in the excited phenol. Still, since tyrosine
is on average three times more abundant than tryptophan in
polypeptides, its signal also differs significantly between the
aggregated and soluble states of proteins.
Methods to Monitor the Conformational
Properties of Amyloid Aggregates
Although the nature and self-assembly mechanisms of
protein amyloids differ, most of them share a final fibrillar
morphology highly enriched in intermolecular cross-β
structure, whose presence can be confirmed by different
biophysical methods.
Circular Dichroism Spectroscopy
Circular dichroism (CD) relies on the differential absorption
of left and right circularly polarized light. Optically active
chiral molecules and chemical groups absorb preferentially
in one direction of the light. Thus, peptide bonds, aromatic
amino acid side chains and disulfide bonds in proteins act
as conformation reporters, providing information about the
secondary structure composition (α-helix, β-sheet, disorder). In
the far UV region of the spectrum (190–260 nm) a maximum
at 196 nm and a single minimum at 218 nm is attributed to
a β-sheet conformation; meanwhile, a maximum at 192 nm
and two minima at 208 nm and 222 nm are indicative of α-
helical content, whereas a minimum at 198 nm correlates with
the presence of disordered regions (Cristovao et al., 2019). The
shift from an initial native conformation to an amyloid β-sheet
structure often exacerbates the minimum at 218 nm (Kelly et al.,
2005; Vadukul et al., 2019). The presence of additional molecules
in the sample, such as reducing agents, organic molecules
and excipients, should be taken into account since they might
interfere with the measurement, precluding detection of the
expected transition.
The far UV spectra of aggregated samples are usually complex
and require the use of deconvolution algorithms (SELCON,
VARSLC, CDSSTR, K2d2, K2d3, BeStSel, DICHROWEB server)
(Provencher and Glockner, 1981; Manavalan and JohnsonJr.,
1987; Andrade et al., 1993; Sreerama and Woody, 2000;
Whitmore and Wallace, 2004; Micsonai et al., 2015) to quantify
the contribution of the different secondary structure elements to
the signal. However, care should be taken with these estimates,
even in the analysis of the variation of secondary structure
content, which should be favored over absolute determinations.
The presence of aggregates often leads to distortions in the
CD spectra (differential absorption flattening) that might lead
to errors in the estimation of secondary structure content, as
most algorithms are optimized for soluble proteins. Of note, one
algorithm – BeStSel – is especially suited for secondary structure
determination of proteins with high β-sheet content, such as
those found in amyloid protein aggregates (Micsonai et al., 2015).
The CD spectrum in the near UV region (260–320 nm) arises
from the contribution from aromatic amino acids and provides
information on the tertiary structure, complementary to that
gathered from intrinsic fluorescence measurements.
Fourier-Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) spectroscopy is especially
suitable to determine the existence of β-sheet secondary
structures in aggregated samples. The presence of a band
at 1620–1640 cm−1 in the amide I region of the infrared
spectrum is a signature of β-strands. Intramolecular (native
β-sheet) signals fall typically in the 1630–1640 cm−1 range,
whereas the intermolecular β-sheets characteristic of aggregates
usually peak at 1620–1630 cm−1 or even lower wavenumbers
(Hiramatsu and Kitagawa, 2005).
The FTIR spectrum is particularly sensitive to the presence
of additives in the sample, such as TFA, DMSO and reducing
agents; therefore, the signal of the buffer should be subtracted
from that of the sample. Because the vibration signal of water
maps in the amide I region (1630 cm−1), the FTIR spectrum must
be obtained by drying out the sample to an hydrated protein film
when using Attenuated Total Reflection sampling devices or by
exchanging H2O with D2O for transmission experiments when
using DTGS (deuterated triglycine sulfate) and MCT (mercuric
cadmium telluride) detectors (Cristovao et al., 2019).
The peaks in the FTIR spectrum are identified by curve
fitting using Fourier self-deconvolution, or/and by analysis of
the inflection points in the second derivative of the spectrum
curve. Fitting of the FTIR spectrum does not provide a unique
solution and thus the fitting parameters become critical: a
minimum number of peaks should be used, the maxima of the
curve-fitted peaks should correspond to the evident maxima in
the raw data, and, generally, curve-fitted peaks should present
similar full-width and half-height values. This technique can
be used to study and compare protein aggregates obtained
in vivo and in vitro (Shivu et al., 2013). Traditional FTIR
analysis only reports on bulk composition and even FTIR
microspectrometers, despite their extensive applications [e.g., in
cell biology (Bouyanfif et al., 2018)], only provide resolution
down to 2–5 µm, which is insufficient for the analysis of
individual fibrils. However, by combining IR with atomic force
microscopy in Infrared Nanospectroscopy it is possible to
acquire both morphological, nanomechanical and nanoscale-
level (10–20 nm) chemical IR absorption spectra and maps
from protein aggregates, single cells and liquid-liquid phase
condensates (Ruggeri et al., 2020). This approach is particularly
useful in analyzing complex mixtures with co-existing amyloid,
amorphous aggregates and pre-fibrillar aggregates with different
secondary structure (Ruggeri et al., 2015, 2016; Galante et al.,
2016; Waeytens et al., 2020).
Proteinase K and Mixture of Proteases Digestion
Complementary to the techniques mentioned above, the relative
resistance of amyloid fibrils to proteinase K digestion is
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commonly used for their characterization, especially in the case
of prionic proteins. Proteinase K is a serine protease that cleaves
peptide bonds on the carboxy-terminal side of aromatic and
aliphatic amino acids. Despite the high processivity of proteinase
K in disordered and regular secondary structures, its proteolytic
activity is rather limited in cross-β-sheet structures, which are
characteristic of amyloid fibrils (Kushnirov et al., 2020). The
identification of proteinase K-resistant amyloid cores can be
achieved by two main approaches: adding different proteinase
K concentrations at the end-times of aggregation reactions or
following the time-course of the digestion at a given proteinase
K concentration. The results of the digestion experiments can
be monitored with several techniques, such as SDS-PAGE
and protein immunoblotting, mass spectrometry, or electron
microscopy. In some cases, a mixture of proteases can be used
instead of proteinase K to identify the core of amyloid fibrils
(Selivanova et al., 2016; Surin et al., 2020).
X-Ray Diffraction and Scattering Techniques
X-ray diffraction and small-angle scattering techniques,
including small-angle X-ray scattering (SAXS) and small-
angle neutron scattering (SANS) are considered gold standard
techniques for the analysis of the structural properties of
amyloid fibrils.
The X-ray fiber diffraction pattern of partially aligned amyloid
fibrils displays a characteristic arrangement with a meridional
reflection (vertical axis) at 4.7–4.8 Å and an equatorial reflection
(horizontal axis) at 10–12 Å (Figure 1B), which report on the
distances between β-strands that are associated via hydrogen-
bonding perpendicular to the fibril axis and between the adjacent
β-sheets running parallel to the axis, respectively. The meridional
signal is generally very sharp and intense due to the repeating
nature of the β-strands along the fiber axis. The equatorial
signal is generally weaker and more diffuse and its position can
vary depending on the amino acid composition of a constituent
peptide (e.g., large aromatic side chains will result in a larger sheet
spacing). This is the reason why the common amyloid fold is
known as cross-β (Morris and Serpell, 2012). Low angle signals
are often also observed, which arise from chain length and/or
protofilament packing.
Small-angle scattering techniques are one of the best-suited
biophysical approaches to study the conformational properties of
the different oligomeric forms appearing along an amyloidogenic
process and how they evolve into mature fibrils. In theory,
one can decompose the time-resolved SAXS and SANS data
into the scattering intensity profiles of the individual forms
(structural information), along with their relative populations
(kinetic information), without the need to isolate the transient or
co-existing species (Langkilde et al., 2015). Nonetheless, the use
of this technique is limited to specific cases because it requires
highly concentrated and stable samples, containing only a few
oligomeric species simultaneously.
Sedimentation Techniques: Separation and Size
Distribution
While complex mixtures of aggregated protein can be imaged
by a variety of different techniques (see section “Morphology
of Amyloid Fibrils”), separation of insoluble species is not
straightforward. An increase in particle mass during protein
aggregation can be exploited for detection, isolation and
characterization of both high-molecular weight intermediates
and final filaments. Several ultracentrifugation protocols have
been adopted for analyzing protein aggregates in cellular and
animal models of various human proteinopathies including prion
protein amyloidosis (Vey et al., 1996), a familiar tauopathy
(Berger et al., 2007) or sporadic AD (Skrabana et al., 2017).
The ability to differentially isolate protein conformers with
distinct physical properties by sedimentation at high speed can
be used also in in vitro experiments of protein aggregation.
Insoluble fibrils and larger aggregates pellet quickly around
14,000–16,000 × g in aqueous buffers, but smaller species
such as oligomers or shorter fibril fragments sediment more
slowly even under high-speed centrifugation above 50,000 × g
(Mok and Howlett, 2006). It is sometimes possible to separate
different fibrils based on their morphology. Straight fibrils of
human apolipoprotein ApoC-II, which dominate in the presence
of phospholipid micelles, sediment more rapidly than flexible
ribbons formed in the absence of lipids, making it possible to
pellet the two populations at 14,500 × g and 350,000 × g,
respectively (Mok et al., 2015). Similar approaches have separated
linear versus closed-loop fibrils of ApoC-II (Yang et al., 2012),
while complex mixtures of huntingtin aggregates have more
simply been fractionated by pelleting a mixture of inclusions,
soluble but large oligomers and cell debris from lysed cells
(14,000 × g for 10 min) followed by centrifugation of the
resuspended pellet through a desalting column, which allows
separating the soluble oligomers from the insoluble material
(Ormsby et al., 2013). Just as importantly, if the relationship
between the molecular weight of fibrillar species and their
diffusion coefficient is known (MacRaild et al., 2003), it is possible
to estimate the size distribution of fibrils using sedimentation
velocity analysis (Yang et al., 2012), which measures how quickly
fibrils move through a centrifugal field. It is even possible to
selectively monitor fibril sizes in the presence of non-fibrillar
components (e.g., chaperones) using fluorescence detection and
fluorophore-labeled fibrils; this allows to assess changes in the
size distribution and lateral association of a given protein (Binger
et al., 2013). As an alternative approach, OptiPrep gradients
have been used to isolate and characterize protein aggregates
associating with membrane-like domains (Vey et al., 1996).
Morphology of Amyloid Fibrils
Once the β-sheet content has been confirmed by the methods
above, the morphology of the amyloid fibrils should be examined
by imaging techniques.
Transmission Electron Microscopy
The visualization of transmission electron microscope (TEM)
images at high resolution provides information on the
morphology, homogeneity and size of the amyloid fibrils.
In order to obtain high-quality TEM data, samples deposited on
carbon-coated copper grids should be negatively stained with a
heavy metal solution [typically 2% (w/v) uranyl acetate solution
in water] to increase contrast. It should, however, be taken into
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account that TEM images may display structural artifacts due to
dehydration and staining during the sample preparation process
(Gras et al., 2011).
Atomic Force Microscopy
Atomic force microscopy (AFM) allows direct visualization of
amyloid fibrils in aqueous solutions, providing information about
their structural and mechanical properties under physiological-
like conditions (Ruggeri et al., 2019). AFM images have
nanometer-resolution, allowing to assess the fibril contour
length, width, height and periodicity or the high-order assembly
of single protofilaments into mature fibrils (Adamcik et al.,
2012). These properties can be measured at final time-
points or directly during the assembly reaction. Besides, it
is possible to define the packing scheme and polymorphic
state of the amyloid fibrils (e.g., twisted, helical ribbon) by
measuring the height profile of fibrils along their contour
length and the shape of height profile. An advantage of
AFM, when compared to TEM, is that it allows measuring
forces and elastic properties of amyloid assemblies with
piconewton resolution.
Several additional methods, such as solid-state NMR and
cryo-EM, provide valuable information about the morphology
and structural features of amyloid fibrils at high resolution.
These methods and their applications to uncover the atomic
structures of amyloid fibrils have been extensively covered in
recent reviews (Iadanza et al., 2018a; Fitzpatrick and Saibil,
2019). Although key to explore correlations between structure
and toxicity, they need advanced equipment and go beyond
a minimum requirement for determining that a polypeptide
assembles into amyloid fibrils.
Fluorescence Techniques and Tinctorial
Properties of Amyloids
It is well established that regular fibrillar structures have the
ability to bind small molecules at their surfaces and cavities with
a concomitant alteration of the optical properties of the binding
compounds. Th-T and CR are two of these molecules, and have
been extensively used for the detection of amyloid structure in
fibrils and deposits.
Thioflavines
The Th-T assay measures the increase in emission fluorescence
signal of Th-T as amyloid fibrils grow. The enhanced fluorescence
can be detected by spectroscopy or visualized by epifluorescence
or confocal microscopy. In all techniques, the molecule is
excited at 445 nm and emission fluorescence is recorded in the
470–500 nm range, usually with a maximum around 482 nm
(Biancalana and Koide, 2010).
Th-T fluorescence enhancement is not a quantitative
parameter since it is strongly dependent on the fibril morphology.
In some cases, amyloid fibrils may be present, but do not display
fluorescence because the rotation movement of the Th-T
molecule is not sufficiently impeded. On these occasions, Th-T
fluorescence anisotropy provides an alternative technique for
the study of amyloid aggregation (Sabate and Saupe, 2007).
Also, the maximum excitation and emission wavelengths may
change slightly depending on each particular amyloid structure
(Sabate et al., 2013).
Th-S is a mixture of compounds that results from the
methylation of dehydrothiotoluidine with sulfonic acid. As
such, its molar concentration cannot be accurately calculated,
which in addition to its high fluorescence background make
this dye sub-optimal for spectroscopic measurements in vitro
(Espargaro et al., 2012). However, Th-S presents the advantage
of being able to permeate through cell membranes, thus
allowing to detect intracellular amyloid aggregates, even in
living cells. Accordingly, it has been vastly used in the
histological staining of amyloids and to image purified amyloid
material (Figure 1C).
Congo Red
The CR dye has been broadly used to detect amyloid aggregates
in tissues and in vitro. The absorption spectra of CR alone and
in the presence of amyloids are recorded in the visible region of
the light spectrum (300–700 nm) and compared (Yakupova et al.,
2019). The binding of CR to amyloids induces a spectral red shift,
with maximum absorbance change occurring around 540 nm. As
in the case of Th-T assays, the CR spectrophotometric assay is
not quantitative.
Birefringence originates from the decomposition of a ray of
light into two rays when it passes through certain anisotropic
materials, such as crystals. The fixation of CR molecules
along the axis of the amyloid fibrils usually causes apple-
green birefringence when viewed through cross-polarized light,
providing an assessment of the amyloid nature of protein
aggregates complementary to CR absorbance measurements.
Other Amyloid-Staining Molecules
The use of Th-T and CR for amyloid detection has limitations.
Many non-amyloid molecules can also exhibit birefringence
under cross-polarized light in the presence of CR, such as
phosphate salts, urea, and other types of fibers like hair.
Moreover, CR is a pH indicator and, accordingly, its absorbance
spectrum is strongly dependent on the solution pH, being useless
under acidic conditions. The absorption and emission spectra
of some molecules, such as flavins and reduced NAD(P)H
overlap with that of Th-T. Also, some polyphenolic anti-
aggregational compounds, such as curcumin or epigallocatechin,
exhibit fluorescent properties similar to those of Th-T (Hudson
et al., 2009). In a similar way, the auto-fluorescence generated by
some aldehyde compounds used as tissue fixatives significantly
interferes with the histological detection of amyloids using
this dye. In light of these problems (Viegas et al., 2007),
novel fluorescent dyes with improved sensitivity and specificity
properties have been developed.
As Th-T, the ProteoStat dye is a rotor molecule that
intercalates into the cross-β structure, leading to a strong red
fluorescence with excitation and emission maxima at 500 nm
and 600 nm, respectively (Shen et al., 2011; Navarro and
Ventura, 2014). Compared to Th-T, ProteoStat staining produces
a stronger fluorescent signal with a wider linear dynamic range
in a broad range of pH values (4–10) and avoids spectral
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TABLE 2 | Experimental details that should be reported for protein aggregation assays.
Reported parameter Information that should be reported
Sample stock Sample source and storage
conditions
Description of protein source – commercial (supplier and reference), recombinant (including
expression and purification), or other (e.g., extracted from tissue); description of how the protein or
peptide stock was preserved (lyophilized or stored in solution); if stored in solution indicate storage
buffer, sample concentration, storage temperature, freezing/thawing conditions, as well as material
and supplier of vials used for sample storage.
Sample purity and
concentration
Indicate the methods (SDS-PAGE, HPLC, etc.) used to determine sample purity, as well as those
used to determine the exact concentration of the stock sample in the assay. The purity of the
sample stock as evaluated by SDS-PAGE should be indicated and higher than 95%. Indicate
whether the sample was tested for the presence of “invisible” components such as nucleic acids.
Sample concentration Indicate the final concentration of the sample in the assay.
Sample preparation prior to
assay
Mention if the protein/peptide stocks were pre-treated, filtered or centrifuged; these procedures are
recommended to remove pre-aggregated forms.
Assay buffer Indicate the composition, concentrations and pH value of the buffer or solvent stock.
Assay volume The final volume of the sample, as well as the volume of the tube/well in which the aggregation
assay is performed should be reported since interfaces (liquid-solid and liquid-air) influence protein
aggregation. The method used to prevent sample evaporation should also be mentioned when
using small sample volumes.
Additives List ALL components that could be found in the aggregation assay (even those that may exist in
minute amounts). For example, if an aggregation modulator is dissolved in DMSO, it is important
that all samples (including control) contain the same final concentration of DMSO.
Experimental procedures,
type of equipment used and
system-dependent parameters
Plate or vial Report the type of material and geometry of the vial or microplate well (binding versus non-binding
surface, bottom versus top-reading, square versus round bottom, etc.) used in the assay. Include
information on the microplate/vial material, including supplier and reference code.
Temperature Report the assay temperature. In particular, mention if samples/buffer are preincubated at the assay
temperature: fluorescence drifts may be observed at the beginning of the experiment resulting from
temperature shifts.
Agitation Indicate whether an orbital shaker, a thermomixer or magnetic stirring was used (describing shape,
size and material of stirrers), the type of shaking (orbital, linear, etc.) and speed. If applicable,
indicate if beads were included (material, size, number of beads). Measurement cycles and the
pre-shaking agitation procedures should be clearly specified.
Time The total duration of the aggregation reaction should be reported.
Equipment for measuring
aggregation kinetics and its
settings
Indicate the device make and model, control software, and general settings used (e.g., filter
bandpass and bandwidth/monochromator settings).
Reporters Provide the exact amount of reporter (if used) employed for measurement and any pre-treatment of
the sample.
Data analysis and raw data
that should be preserved
for publication
Indicate the software (including version) used for image and data analysis and specify the equation
applied for fitting kinetic data obtained from aggregation assays.
overlap with the autofluorescence signal of membranes and co-
factors. ProteoStat is particularly indicated if working in the
presence of RNA, when the use of Th-T is unsuited, because it
produces huge distortions of the baseline (Sugimoto et al., 2015;
Liu et al., 2017).
Heptamer-formyl thiophene acetic acid (hFTAA) is yet
another amyloid detection dye. hFTAA exhibits distinct shifts
in its emission spectra when bound to different amyloid species
and polymorphs, finding application in the differentiation of
amyloid (sub)types in vivo and in monitoring changes of amyloid
structure and composition over time (Klingstedt et al., 2011,
2013; Sjolander et al., 2016).
Molecules such as 1-anilinonaphthalene-8-sulfonate (ANS)
and its dimeric analog 4,4′-bis-1-anilinonaphthalene-8-sulfonate
(Bis-ANS) are barely fluorescent in polar solvent, but become
highly fluorescent in an apolar environment. In the presence
of aggregates a blue shift and an increase of their emission
maxima occur, due to their binding to the hydrophobic
clusters exposed in such assemblies. ANS and bis-ANS are
particularly useful in the detection of the low concentrations of
protein aggregates populating the early stages of the reaction
(de Groot et al., 2007).
A Th-T derivative, called Pittsburgh compound B (PiB) is
able to enter the brain and is used as a radioactive tracer
for in vivo PET imaging of amyloid beta pathology in AD
(Klunk et al., 2004).
GUIDELINES FOR REPORTING PROTEIN
AGGREGATION EXPERIMENTS: THE
MIRRAGGE TABLE
Given the diversity of oligomeric species and folding states,
the choice of protein purification and handling procedures
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FIGURE 3 | Aggregation of human ataxin-3 (UniProt accession code: P54252-2). (A) Schematic representation of the structural organization of ataxin-3, with the
N-terminal globular Josephin domain (JD) and the flexible C-terminal tail encompassing the ubiquitin-interacting motifs (UIMs) and the polyQ tract containing 13
glutamine residues (13Q); (B) Representative graph of human ataxin-3 aggregation at 37◦C monitored by Th-T fluorescence. (C) TEM image of ataxin-3 protofibrils
at the end of the aggregation assay (∼60 h).
plays a crucial role in determining where in the aggregation
map (Figure 2) are the departing and arrival points located,
and by what pathways are they connected. Therefore, we
propose a set of guidelines for presentation and publication
of data related to polypeptide aggregation that ensure an
adequate and accurate description of the experimental results.
The relevant information that we propose to be reported
is divided into two parts: sample preparation and quality
and incubation conditions. Ideally, the methods section
of each publication should contain the information briefly
described in Table 2.
A pre-filled MIRRAGGE table using the aggregation of
the protein ataxin-3 (Figure 3) (Gales et al., 2005; Almeida
et al., 2015) and of a peptide from the Mot3 yeast prion
(Sant’Anna et al., 2016; Fernandez et al., 2017) as examples
is provided as Supplementary Information (Supplementary
File MIRRAGGE_template.xls) illustrating the minimum
information that we suggest should be included to ensure
reproducible (poly)peptide aggregation experiments. A large
part of the minimum information required in the MIRRAGGE
table concerns the sample preparation steps that precede
the aggregation assay itself. Starting by the unambiguous
identification of the protein molecule, it is particularly
important for curators of public databases that the UniProt
accession number, the species of origin and, if applicable, the
presence of affinity tags are provided for the molecules under
investigation (Orchard et al., 2007; Trewhella et al., 2017).
For synthetic peptides, the chemical nature of the N and C
termini (whether capped or uncapped) should be made clear
as well as the buffering salt (e.g., TFA). Besides the essential
information about the sample source, namely the protein
expression system, the purification and polishing protocols,
or, in the case of samples obtained from commercial sources,
the catalog number and the name and location of the supplier,
the MIRRAGGE table can also encompass any additional
information or experimental detail found to be important for
the outcome of aggregation. This is acchieved by including a
flexible field of “additional key information” at the end of the
tabular descriptions of the purification protocol and of the
aggregation assay, wherein relevant remarks concerning the
aggregation state of the protein, sample collection procedures in
gel filtration chromatography, the occurrence of contaminants
or co-solvents, the procedure adopted for removal of air bubbles,
a critical sequence of reagent addition, etc., can be emphasized.
A comprehensive characterization of the aggregation assay
in terms of the total volume of reaction, plate/cuvette/vial
geometry and material, method of evaporation control, size
and material of beads (if present), and type of agitation is
required on account of the effects of interfaces and shear
flow on protein aggregation (Giehm and Otzen, 2010; Bekard
et al., 2011; Yoshimura et al., 2012; Ferreira et al., 2016; Koepf
et al., 2018). As a major determinant of phase separation,
protein concentration is discriminated (i) before storage of
the purified protein, (ii) immediately before aggregation, e.g.,
after the final filtration step, and (iii) during aggregation. The
concentration of protein or peptide is provided, together with
the information about MW, extinction coefficient and the
quantification method adopted. Freeze-thawing stress can lead
to the cold denaturation of the protein, its adsorption at the
ice-liquid interface with subsequent partial denaturation and
aggregation, or to drastic pH changes in buffers like sodium
phosphate or succinate (Hawe et al., 2009). It is recommended
to control the quality of thawed samples to judge whether
additional polishing steps are required before the aggregation
assay. Cohen et al. (2013) reported two rounds of gel filtration
post-thawing on purified Aβ42 peptide to ensure pure monomer
at the beginning of the kinetic assay. In the case of ataxin-3,
increased reproducibility is achieved by adding a re-polishing
step immediately before the aggregation assay, separating
the predominant monomer from contaminant oligomeric
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species putatively formed during the freezing-thawing process
(Silva et al., 2017).
In conclusion, this review aims to provide an overview
of the biophysical principles underlying protein self-assembly
in its multiple shapes, and compiles detailed information
on the experimental validation of polypeptide aggregation,
with a focus on amyloid fibril formation. It results from
several discussions on this topic in the context of the COST
action BM1405 [Non-globular proteins – from sequence
to structure, to applications in molecular physiopathology
(NGP-net)]. We aim to endow both experienced researchers
and newcomers to the field with a set of guidelines
to enhance reproducibility in (poly)peptide aggregation
experiments. The MIRRAGGE table template compiles a
recommended reporting framework that is expected to provide
a minimum set of information required for replicating
protein aggregation experiments and swiftly discriminate
protein assembly into amyloid fibrils from amorphous
protein aggregation.
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